PMC:7228307 / 54094-54263 JSONTXT

{"project":"LitCovid-PubTator","denotations":[{"id":"1110","span":{"begin":42,"end":49},"obj":"Gene"},{"id":"1111","span":{"begin":70,"end":74},"obj":"Gene"}],"attributes":[{"id":"A1110","pred":"tao:has_database_id","subj":"1110","obj":"Gene:2213"},{"id":"A1111","pred":"tao:has_database_id","subj":"1111","obj":"Gene:2213"}],"namespaces":[{"prefix":"Tax","uri":"https://www.ncbi.nlm.nih.gov/taxonomy/"},{"prefix":"MESH","uri":"https://id.nlm.nih.gov/mesh/"},{"prefix":"Gene","uri":"https://www.ncbi.nlm.nih.gov/gene/"},{"prefix":"CVCL","uri":"https://web.expasy.org/cellosaurus/CVCL_"}],"text":"Preferential or specific Fc engagement of FcγRIIb over the activating FcγR offers several potential therapeutic advantages for new mAbs in distinct therapeutic settings."}

{"project":"LitCovid-PD-CLO","denotations":[{"id":"T913","span":{"begin":25,"end":27},"obj":"http://purl.obolibrary.org/obo/CLO_0052676"},{"id":"T914","span":{"begin":42,"end":44},"obj":"http://purl.obolibrary.org/obo/CLO_0052676"},{"id":"T915","span":{"begin":59,"end":69},"obj":"http://purl.obolibrary.org/obo/CLO_0001658"},{"id":"T916","span":{"begin":70,"end":72},"obj":"http://purl.obolibrary.org/obo/CLO_0052676"}],"text":"Preferential or specific Fc engagement of FcγRIIb over the activating FcγR offers several potential therapeutic advantages for new mAbs in distinct therapeutic settings."}

{"project":"LitCovid-sample-Pubtator","denotations":[{"id":"1110","span":{"begin":42,"end":49},"obj":"Gene"},{"id":"1111","span":{"begin":70,"end":74},"obj":"Gene"}],"attributes":[{"id":"A1111","pred":"pubann:denotes","subj":"1111","obj":"Gene:2213"},{"id":"A1110","pred":"pubann:denotes","subj":"1110","obj":"Gene:2213"}],"text":"Preferential or specific Fc engagement of FcγRIIb over the activating FcγR offers several potential therapeutic advantages for new mAbs in distinct therapeutic settings."}

{"project":"LitCovid-sample-sentences","denotations":[{"id":"T308","span":{"begin":0,"end":169},"obj":"Sentence"}],"namespaces":[{"prefix":"_base","uri":"http://pubannotation.org/ontology/tao.owl#"}],"text":"Preferential or specific Fc engagement of FcγRIIb over the activating FcγR offers several potential therapeutic advantages for new mAbs in distinct therapeutic settings."}

{"project":"LitCovid-sentences","denotations":[{"id":"T308","span":{"begin":0,"end":169},"obj":"Sentence"}],"namespaces":[{"prefix":"_base","uri":"http://pubannotation.org/ontology/tao.owl#"}],"text":"Preferential or specific Fc engagement of FcγRIIb over the activating FcγR offers several potential therapeutic advantages for new mAbs in distinct therapeutic settings."}